Phibro Animal Health Corporation
PAHCNASDAQHealthcareDrug Manufacturers - Specialty & Generic
As of Oct 23, 2026 close
- Market cap
- $1.59B
- P/E (TTM)
- 15.94
- Forward P/E
- 8.18
- Dividend yield
- 1.21%
- 52-week range
- $28.25$60.08
- Volume (live)
- -
- Avg. volume (3M)
- 236.75K
Phibro Animal Health (PAHC) Stock Price & Financial Analysis
Phibro Animal Health Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $38.62 - $39.51 |
|---|---|
| 52-Week High | $60.08 |
| 52-Week Low | $28.25 |
| Open | $39.51 |
| Volume (last close) | 102.75K |
| Average Volume (3M) | 236.75K |
| Revenue (TTM) | 1.52B |
|---|---|
| Net Income (TTM) | 99.72M |
| Free Cash Flow (TTM) | 9.87M |
| EPS (TTM) | $2.43 |
| Profit Margin | 6.57% |
| Operating Margin | 13.02% |
| Return on Equity (ROE) | 25.87% |
| Debt to Equity | 2.05 |
| Annual Dividend | $0.48 |
|---|---|
| Dividend Yield | 1.21% |
| Payout Ratio | 19.72% |
| Last Dividend Ex-Date | Sep 2, 2026 |
| Market Cap | 1.59B |
|---|---|
| Shares Outstanding | 40.96M |
| P/E Ratio (TTM) | 15.94 |
| Forward P/E | 8.18 |
| Price to Sales (P/S) | 1.05 |
| Price to Book (P/B) | 4.12 |
| EV/EBITDA | 10.14 |
| 50-Day MA | $36.30 |
|---|---|
| 200-Day MA | $41.29 |
| 1-Year Change | −3.02% |
Source: Market prices and company fundamentals. Data as of Oct 23, 2026. Data sources and methodology
Phibro Animal Health at a Glance
As of the Oct 23, 2026 close, Phibro Animal Health (PAHC) has a market capitalization of $1.59B. The stock trades at 15.9× trailing earnings, 8.2× forward earnings and 1.1× sales. Over the trailing twelve months it earned $99.72M on revenue of $1.52B (a 6.6% profit margin) and generated $9.87M of free cash flow. Revenue grew 17.1% year over year.
As of its latest reported balance sheet, it holds $61.42M in cash and securities against $788.77M of debt, a net debt position of $727.35M.
Phibro Animal Health pays a quarterly dividend totaling $0.48 per share a year, a 1.21% yield at the Oct 23, 2026 close, with a 20% payout ratio.
The share price is down 3.0% over the past year. At $38.80 (the Oct 23, 2026 close) it sits within its 52-week range of $28.25 to $60.08, below its 200-day moving average of $41.29.
Based on 2 professional analyst ratings from the past 90 days, the consensus is Buy.
Frequently Asked Questions About Phibro Animal Health
What is the current stock price for PAHC?
As of the Oct 23, 2026 close, PAHC stock trades at $38.80. The 52-week range is $28.25–$60.08, with a day range of $38.62–$39.51.
What is the P/E ratio for PAHC?
As of the Oct 23, 2026 close, Phibro Animal Health's trailing twelve-month (TTM) P/E ratio is 15.9, meaning investors pay $15.9 for every $1 of annual earnings. The forward P/E is 8.2, reflecting analyst expectations for future earnings. Phibro Animal Health operates in the Healthcare sector.
Does PAHC pay dividends?
Yes, Phibro Animal Health pays a 1.21% annual dividend yield as of the Oct 23, 2026 close ($0.48 per share a year). The trailing twelve-month payout ratio is 19.7%. The most recent ex-dividend date was September 2, 2026.
What do analysts recommend for PAHC?
Based on ratings from 2 professional analysts over the last 90 days, the consensus for PAHC is Buy.
What is the market cap of PAHC?
As of the Oct 23, 2026 close, Phibro Animal Health's market capitalization is $1.59B, classifying it as a small-cap company. Phibro Animal Health operates in the Healthcare sector within the Drug Manufacturers - Specialty & Generic industry.